E.O.S Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$366M
E.O.S General Information
Description
Developer of medicines for the treatment of cancer. The company also provides anti-proliferative agents and multikinase inhibitors.
Contact Information
Website
www.eosmilano.comCorporate Office
- Via Monte di Pietà 1 / A
- 20121 Milan(Lombardy)
- Italy
Corporate Office
- Via Monte di Pietà 1 / A
- 20121 Milan(Lombardy)
- Italy
E.O.S Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 19-Nov-2013 | $366M | Completed | Clinical Trials - Phase 2 | ||
| 2. Early Stage VC (Series A) | 01-Jul-2009 | Completed | Product Development | |||
| 1. Seed Round | 28-Jun-2007 | $6.05M | $6.05M | Completed | Startup |
E.O.S Patents
E.O.S Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3162274-A1 | Time-temperature indicator | Pending | 12-Nov-2019 | ||
| EP-4058764-A1 | Time-temperature indicator | Active | 12-Nov-2019 | ||
| EP-4058764-B1 | Time-temperature indicator | Active | 12-Nov-2019 | ||
| EP-4058764-C0 | Time-temperature indicator | Active | 12-Nov-2019 | ||
| US-12287245-B2 | Time-temperature indicator | Active | 12-Nov-2019 | G01K3/04 |
E.O.S Signals
E.O.S Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aescap Life Sciences | Mutual Fund | Minority | ||
| Sofinnova Partners | Venture Capital | Minority | ||
| Xyence | Venture Capital | Minority |
E.O.S FAQs
-
When was E.O.S founded?
E.O.S was founded in 2006.
-
Where is E.O.S headquartered?
E.O.S is headquartered in Milan, Italy.
-
What is the size of E.O.S?
E.O.S has 11 total employees.
-
What industry is E.O.S in?
E.O.S’s primary industry is Drug Discovery.
-
Is E.O.S a private or public company?
E.O.S is a Private company.
-
What is the current valuation of E.O.S?
The current valuation of E.O.S is .
-
What is E.O.S’s current revenue?
The current revenue for E.O.S is .
-
How much funding has E.O.S raised over time?
E.O.S has raised $23.1M.
-
Who are E.O.S’s investors?
Aescap Life Sciences, Sofinnova Partners, and Xyence have invested in E.O.S.
-
When was E.O.S acquired?
E.O.S was acquired on 19-Nov-2013.
-
Who acquired E.O.S?
E.O.S was acquired by Clovis Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process